Home  >  News
Eppen_CellXpert_Mar2026
you can get e-magazine links on WhatsApp. Click here
News
  ASPA–CRISIL “State of Counterfeiting in India 2025” report reveals counterfeit medicines account for around 28% of the market,   March 17, 2026
  Lupin and Zydus ink licensing agreement to co-market innovative semaglutide injection in India,   March 17, 2026
  Zuellig Pharma acquires Cialis from Lilly in three additional markets in Asia,   March 14, 2026
  Breckenridge Pharma partners with Maiva Pharma to supply sterile injectables to hospitals and clinics in US,   March 13, 2026
  Hutchmed announces update on licensed oncology product Tazverik in China,   March 11, 2026
  Galderma introduces Cetaphil AM/PM Antioxidant Serums, a new science-driven defense and recovery system for sensitive skin,   March 10, 2026
  UK MHRA?announces precautionary recall of blood pressure medication after packaging error,   March 09, 2026
  GAIA, Daiichi Sankyo Europe partner to commercialize next-generation digital therapeutic ‘lipodia’ for cardiovascular care,   March 07, 2026
  Alembic Pharma announces first prescription sale of Pivya following US commercial launch,   March 06, 2026
  Ipsen receives CHMP’s positive opinion on Ojemda for treating monotherapy of children with relapsed or refractory BRAF-altered paediatric low-grade glioma,   March 04, 2026
  EMA recommends marketing authorisation to Norgine’s mavorixafor in patients aged 12 years and older to treat of WHIM syndrome,   March 04, 2026
  Emcure and Roche ink distribution pact strengthen nephrology and transplant care in India,   March 02, 2026
  Photocure announces EMA accepts its partner Asieris Pharma’s MAA for Cevira to treat high-grade squamous intraepithelial lesions,   March 02, 2026
  RedHill Biopharma announces full sales and operational launch of Talicia in US,   February 27, 2026
  Zydus plans to launch innovative semaglutide injection in India on day 1 of patent expiry,   February 26, 2026
  UK MHRA grants marketing approval to Eli Lilly’s imlunestrant tosylate to treat breast cancer,   February 26, 2026
  Bayer expands Nubeqa in India as a treatment option without chemotherapy for men with metastatic hormone sensitive prostate cancer,   February 24, 2026
  Formosa Pharma inks licensing agreement with Arrotex for commercialization of clobetasol propionate ophthalmic suspension to treat inflammation and pain following ocular surgery,   February 24, 2026
  Indoco Remedies receives US FDA final approval to market brivaracetam oral solution, 10 mg/mL,   February 24, 2026
  UK MHRA grants marketing authorisation to Insmed Netherlands’ brensocatib to treat patients 12 years and older with non-cystic fibrosis bronchiectasis,   February 24, 2026

  • Results Found: 7200
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 360
 Back
 
Propak_Asia_2026
CP_CPHI_Korea2026
IWE_CP_2026
ChemExpo_India_2026
PharmaTech_expo_Chandigarh2026
ASIA_PHARMA_EXPO_2026
CPHI_Japan26
Ana_Lab_India_2026
PharmaCore_India_2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram